Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs
- PMID: 1531699
- DOI: 10.1038/356071a0
Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs
Abstract
Activation of receptor-linked and cytoplasmic protein tyrosine kinases is crucial in the control of normal and abnormal cell growth and differentiation. Some substrates of protein tyrosine kinases such as phospholipase C gamma and ras GTPase-activating protein (GAP) contain sequences homologous to the src protein domains SH2 and SH3 (refs 3-9). The proto-oncogene vav is expressed in haematopoietic cells and its product Vav contains sequence motifs commonly found in transcription factors, such as helix-loop-helix, leucine-zipper and zinc-finger motifs and nuclear localization signals, as well as a single SH2 and two SH3 domains. Here we show that stimulation of T-cell antigen receptor on normal human peripheral blood lymphocytes or on human leukaemic T cells, and the crosslinking of IgE receptors on rat basophilic leukaemia cells, both promote the phosphorylation of tyrosine residues in Vav. Moreover, activation of the receptor for epidermal growth factor leads to marked tyrosine phosphorylation of Vav in cells transiently expressing vav, and Vav associates with the receptor through its SH2 domain. We propose that vav encodes a new class of substrates whose tyrosine phosphorylation may provide a mechanism for direct signal transduction linking receptors at the cell surface to transcriptional control.
Comment in
-
Proto-vav and gene expression.Nature. 1992 Jul 9;358(6382):113. doi: 10.1038/358113a0. Nature. 1992. PMID: 1614545 No abstract available.
Similar articles
-
Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates.Nature. 1992 Mar 5;356(6364):68-71. doi: 10.1038/356068a0. Nature. 1992. PMID: 1311423
-
Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav.Oncogene. 1993 Jul;8(7):1757-63. Oncogene. 1993. PMID: 8510922
-
Insulin-like growth factor-1 induces rapid tyrosine phosphorylation of the vav proto-oncogene product.Exp Hematol. 1996 Apr;24(5):622-7. Exp Hematol. 1996. PMID: 8605967
-
Vav: Captain Hook for signal transduction?Crit Rev Oncog. 1995;6(2):87-97. Crit Rev Oncog. 1995. PMID: 8792085 Review.
-
[Lymphocytes: what is "Vav"].Med Sci (Paris). 2003 Feb;19(2):217-22. doi: 10.1051/medsci/2003192217. Med Sci (Paris). 2003. PMID: 12836616 Review. French.
Cited by
-
The SH2 and SH3 domain-containing Nck protein is oncogenic and a common target for phosphorylation by different surface receptors.Mol Cell Biol. 1992 Dec;12(12):5824-33. doi: 10.1128/mcb.12.12.5824-5833.1992. Mol Cell Biol. 1992. PMID: 1333047 Free PMC article.
-
WIP regulates signaling via the high affinity receptor for immunoglobulin E in mast cells.J Exp Med. 2004 Feb 2;199(3):357-68. doi: 10.1084/jem.20030652. J Exp Med. 2004. PMID: 14757742 Free PMC article.
-
Evidence of off-target effects of bosutinib that promote retinoic acid-induced differentiation of non-APL AML cells.Cell Cycle. 2021 Dec;20(24):2638-2651. doi: 10.1080/15384101.2021.2005275. Epub 2021 Nov 26. Cell Cycle. 2021. PMID: 34836491 Free PMC article.
-
Interleukin-2 induces tyrosine phosphorylation of the vav proto-oncogene product in human T cells: lack of requirement for the tyrosine kinase lck.Biochem J. 1993 Sep 1;294 ( Pt 2)(Pt 2):339-42. doi: 10.1042/bj2940339. Biochem J. 1993. PMID: 7690544 Free PMC article.
-
The vav proto-oncogene is required early in embryogenesis but not for hematopoietic development in vitro.EMBO J. 1995 Jan 3;14(1):1-11. doi: 10.1002/j.1460-2075.1995.tb06969.x. EMBO J. 1995. PMID: 7828581 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous